Charles Dadswell
General Counsel en ILLUMINA, INC. .
Fortuna: 3 M $ al 31/03/2024
Perfil
En la actualidad, Charles E. Dadswell es secretario, vicepresidente senior y responsable de cumplimiento de Illumina, Inc. En su trayectoria profesional anterior, el Sr. Dadswell fue Consejero General de BioDelivery Sciences International, Inc., Vicepresidente de Propiedad Intelectual de EE.UU. en GlaxoSmithKline, Inc., Director de Glaxo Wellcome, Inc. y Vicepresidente y Consejero General de América del Norte y América Latina en bioMerieux, Inc. Charles E. Dadswell se licenció en la Universidad Estatal de Ferris (Michigan), se graduó en la Facultad de Derecho Thomas M. Cooley y se licenció en la Facultad de Derecho de la Universidad George Washington.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ILLUMINA, INC.
0.01% | 05/03/2024 | 22 298 ( 0.01% ) | 3 M $ | 31/03/2024 |
Cargos activos de Charles Dadswell
| Empresas | Cargo | Inicio |
|---|---|---|
| ILLUMINA, INC. | General Counsel | 22/04/2013 |
Antiguos cargos conocidos de Charles Dadswell.
| Empresas | Cargo | Fin |
|---|---|---|
bioMérieux, Inc.
 bioMérieux, Inc. Medical SpecialtiesHealth Technology bioMérieux, Inc. develops in-vitro diagnostics solutions. It offers microbiological testing solutions for medical and industrial applications. The company was founded on December 31, 1986 and is headquartered in Durham, NC. | General Counsel | 01/04/2013 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | General Counsel | 01/01/2010 |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
GlaxoSmithKline, Inc.
 GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
Formación de Charles Dadswell.
| Ferris State University (Michigan) | Undergraduate Degree |
| The Thomas M. Cooley Law School | Graduate Degree |
| George Washington University Law School | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ILLUMINA, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
bioMérieux, Inc.
bioMérieux, Inc. Medical SpecialtiesHealth Technology bioMérieux, Inc. develops in-vitro diagnostics solutions. It offers microbiological testing solutions for medical and industrial applications. The company was founded on December 31, 1986 and is headquartered in Durham, NC. | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
- Bolsa de valores
- Insiders
- Charles Dadswell
